Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Catalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a metal-free, air-stable C2-phosphono indole synthesis method with >99% purity, high atom economy, and scalable production for pharmaceutical applications.
Solve asymmetric synthesis challenges with novel chiral nitrogen-diene ligands. 99% yield, 90% ee, and water-tolerant processes reduce production costs for pharma R&D and manufacturing.
Solve asymmetric synthesis challenges with novel chiral nitrogen-diene ligands. 99% yield, 90% ee in rhodium-catalyzed reactions. Scale to 100 MT/annual with NINGBO INNO PHARMCHEM.
Eliminate chiral column costs with novel crystallization-based resolution. Achieve >99% ee and 76-78% yield for 6,6'-dihydroxy-5,5'-bisquinoline. Scale to 100MT/yr with NINGBO INNO PHARMCHEM's CDMO expertise.
Discover how symmetric bispiperidine metal complexes solve multi-step synthesis challenges in API manufacturing with >99% selectivity and reduced supply chain risks for pharma R&D and production teams.
Discover a breakthrough synthesis method for chiral fluorine-containing quaternary carbon compounds with >90% enantioselectivity and mild conditions. Reduce supply chain risks for your API development.
Discover how asymmetric Povarov reaction with cobalt catalysts enables high-yield, enantioselective synthesis of chiral tetrahydroquinolines for drug development.
Discover how this dual-chiral ligand enables 91% ee in asymmetric reactions, reducing R&D costs and supply chain risks for pharmaceutical intermediates.
Discover efficient synthesis of axial chiral indole-naphthalene with >95% er, mild conditions, and scalable production. Reduce R&D costs and supply chain risks for asymmetric catalysis applications.
Solve high catalyst loading issues in asymmetric hydrogenation. Our CDMO expertise delivers 99% yield, 97% ee at 0.02 mol% catalyst for chiral APIs and flavors.
Solve low enantioselectivity in copper-catalyzed trifluoromethylation with novel quinoline-bisoxazoline ligands. Achieve >95% ee and 70% yield for chiral beta-trifluoromethyl ketones. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.
Discover how this novel chiral synthesis method achieves >90% optical purity with low-cost reagents, reducing production costs and supply chain risks for pharmaceutical manufacturers.
Efficient, high-yield synthesis of axial chiral indole-naphthalene compounds with >95% ee. Reduce R&D costs and supply chain risks for asymmetric catalysis applications.
Discover a scalable chiral ligand synthesis method with 80%+ yield, eliminating column chromatography to cut costs and environmental impact. Ideal for API manufacturing.
Boost enantioselectivity in alpha-hydroxy-beta-keto ester synthesis with our large steric hindrance catalysts. Reduce costs, ensure GMP compliance, and scale efficiently. Contact us for custom synthesis.
Discover a breakthrough chiral rhodium-catalyzed method for carbon-nitrogen axial chiral indole-naphthol compounds with 96%ee, mild conditions, and high yield. Reduce R&D costs and supply chain risks for your API synthesis.
Discover one-step, high-yield synthesis of axial chiral indole-naphthalene with >95% ee. Reduce R&D costs and supply chain risks for asymmetric catalysts in pharma development.
Analyzing the solvent-free synthesis of Pybox ligands. Discover how this new method achieves high yield and enables asymmetric catalysis with validation and scale-up potential.
Struggling with low enantioselectivity in α,β-diamino acid synthesis? Discover emerging biaryl chiral catalysts for efficient, scalable Mannich reactions. Find reliable suppliers for high-purity intermediates.
Overcome thiamphenicol synthesis challenges with chiral catalysis: reduce waste, improve yield, and ensure GMP compliance. Find reliable suppliers for high-purity API.